We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Top Buys
| 1 |
SPLK
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
UnitedHealth
UNH
$386B
| $8.5M | 0.01% |
16,034
| – | – |
|
|
GTM
252
ZoomInfo Technologies
GTM
$890M
| $8.3M | 0.01% |
275,569
-2,950
| -1% | -$102K |
|
253
Darden Restaurants
DRI
$22.4B
| $8.26M | 0.01% |
59,700
| – | – |
|
|
CYBR
254
DELISTED
CyberArk
CYBR
| $8.2M | 0.01% |
63,250
-16,100
| -20% | -$2.33M |
|
255
Repligen
RGEN
$8.3B
| $8.02M | 0.01% |
47,379
| – | – |
|
256
New Fortress Energy
NFE
$100M
| $7.95M | 0.01% |
187,300
+1,700
| +0.9% | +$82.1K |
|
257
SLB Ltd
SLB
$71.1B
| $7.86M | 0.01% |
147,100
+8,000
| +6% | +$398K |
|
|
PRO
258
DELISTED
PROS Holdings
PRO
| $7.71M | 0.01% |
317,630
-29,660
| -9% | -$727K |
|
259
Enovis
ENOV
$1.42B
| $7.66M | 0.01% |
143,066
| – | – |
|
260
Ambarella
AMBA
$3.2B
| $7.52M | 0.01% |
91,400
-22,300
| -20% | -$1.48M |
|
261
DoorDash
DASH
$81.8B
| $7.13M | 0.01% |
145,990
-300
| -0.2% | -$15.6K |
|
262
Constellation Brands
STZ
$22.4B
| $6.98M | 0.01% |
30,100
| – | – |
|
263
BridgeBio Pharma
BBIO
$16.5B
| $6.96M | 0.01% |
913,292
-124,438
| -12% | -$1.19M |
|
264
ESAB
ESAB
$5.42B
| $6.71M | 0.01% |
143,065
| – | – |
|
265
Omnicell
OMCL
$2.09B
| $6.61M | 0.01% |
131,107
+21,850
| +20% | +$1.31M |
|
266
Rapid7
RPD
$867M
| $6.58M | 0.01% |
193,500
+12,900
| +7% | +$461K |
|
267
Rivian
RIVN
$25.3B
| $6.4M | 0.01% |
347,500
-4,520
| -1% | -$133K |
|
268
GitLab
GTLB
$5.57B
| $5.99M | 0.01% |
131,790
-1,030
| -0.8% | -$46.5K |
|
269
Dollar General
DG
$26.5B
| $5.81M | 0.01% |
23,600
+6,500
| +38% | +$1.61M |
|
|
AMK
270
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $5.79M | 0.01% |
251,700
| – | – |
|
271
EPR Properties
EPR
$4.56B
| $5.59M | 0.01% |
148,280
-23,720
| -14% | -$923K |
|
272
Guardant Health
GH
$21.2B
| $5.5M | 0.01% |
202,044
-27,000
| -12% | -$1.24M |
|
273
Standard BioTools
LAB
$328M
| $5.4M | ﹤0.01% |
4,616,673
-310,070
| -6% | -$382K |
|
274
Ciena
CIEN
$63.3B
| $5.17M | ﹤0.01% |
101,485
+1,000
| +1% | +$45.2K |
|
275
Health Catalyst
HCAT
$169M
| $5.01M | ﹤0.01% |
471,334
-910
| -0.2% | -$8.79K |
|
Similar funds
